Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?

Mariko Ikeda, Hiroki Kurahashi, Satoru Noguchi, Jun Sese, Takeshi Okinaga, Toshifumi Tsukahara, Pascale Guicheney, Keiichi Ozono, Ichizo Nishino, Shinichi Morishita, Tatsushi Toda

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Fukuyama-type congenital muscular dystrophy (FCMD) and laminin-α2 deficient congenital muscular dystrophy (MDC1A) are congenital muscular dystrophies (CMDs) and they both are categorized into the same clinical entity of muscular dystrophy as Duchenne muscular dystrophy (DMD). All three disorders share a common etiologic defect in the dystrophin-glycoprotein complex, which connects muscle structural proteins with the extracellular basement membrane. To investigate the pathophysiology of these CMDs, we generated microarray gene expression profiles of skeletal muscle from patients in various clinical stages. Despite diverse pathological changes, the correlation coefficient of overall gene expression among these samples was considerably high. We performed a multi-dimensional statistical analysis, the Distillation, to extract determinant genes that distinguish CMD muscle from normal controls. Up-regulated genes were primarily extracellular matrix (ECM) components, whereas down-regulated genes included structural components of mature muscle. These observations reflect active interstitial fibrosis with less active regeneration of muscle cell components in the CMDs, characteristics that are clearly distinct from those of DMD. Although the severity of fibrosis varied among the specimens tested, ECM gene expression was consistently high without substantial changes through the clinical course. Further, in situ hybridization showed more prominent ECM gene expression on muscle cells than on interstitial tissue cells, suggesting that ECM components are induced by regeneration process rather than by 'dystrophy.' These data imply that the etiology of FCMD and MDC1A differs from that of the chronic phase of classical muscular dystrophy, and the major pathophysiologic change in CMDs might instead result from primary active fibrosis.

Original languageEnglish
Pages (from-to)489-502
Number of pages14
JournalBiochemical and Biophysical Research Communications
Volume342
Issue number2
DOIs
Publication statusPublished - 07-04-2006

Fingerprint

Walker-Warburg Syndrome
Muscular Dystrophies
Laminin
Muscle
Gene expression
Muscles
Extracellular Matrix
Genes
Fibrosis
Duchenne Muscular Dystrophy
Gene Expression
Cells
Muscle Cells
Regeneration
Dystrophin
Microarrays
Distillation
Muscle Proteins
Statistical methods
Glycoproteins

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Ikeda, Mariko ; Kurahashi, Hiroki ; Noguchi, Satoru ; Sese, Jun ; Okinaga, Takeshi ; Tsukahara, Toshifumi ; Guicheney, Pascale ; Ozono, Keiichi ; Nishino, Ichizo ; Morishita, Shinichi ; Toda, Tatsushi. / Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 342, No. 2. pp. 489-502.
@article{8e0426df58ea4e108be3eb31234c286a,
title = "Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?",
abstract = "Fukuyama-type congenital muscular dystrophy (FCMD) and laminin-α2 deficient congenital muscular dystrophy (MDC1A) are congenital muscular dystrophies (CMDs) and they both are categorized into the same clinical entity of muscular dystrophy as Duchenne muscular dystrophy (DMD). All three disorders share a common etiologic defect in the dystrophin-glycoprotein complex, which connects muscle structural proteins with the extracellular basement membrane. To investigate the pathophysiology of these CMDs, we generated microarray gene expression profiles of skeletal muscle from patients in various clinical stages. Despite diverse pathological changes, the correlation coefficient of overall gene expression among these samples was considerably high. We performed a multi-dimensional statistical analysis, the Distillation, to extract determinant genes that distinguish CMD muscle from normal controls. Up-regulated genes were primarily extracellular matrix (ECM) components, whereas down-regulated genes included structural components of mature muscle. These observations reflect active interstitial fibrosis with less active regeneration of muscle cell components in the CMDs, characteristics that are clearly distinct from those of DMD. Although the severity of fibrosis varied among the specimens tested, ECM gene expression was consistently high without substantial changes through the clinical course. Further, in situ hybridization showed more prominent ECM gene expression on muscle cells than on interstitial tissue cells, suggesting that ECM components are induced by regeneration process rather than by 'dystrophy.' These data imply that the etiology of FCMD and MDC1A differs from that of the chronic phase of classical muscular dystrophy, and the major pathophysiologic change in CMDs might instead result from primary active fibrosis.",
author = "Mariko Ikeda and Hiroki Kurahashi and Satoru Noguchi and Jun Sese and Takeshi Okinaga and Toshifumi Tsukahara and Pascale Guicheney and Keiichi Ozono and Ichizo Nishino and Shinichi Morishita and Tatsushi Toda",
year = "2006",
month = "4",
day = "7",
doi = "10.1016/j.bbrc.2005.12.224",
language = "English",
volume = "342",
pages = "489--502",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease? / Ikeda, Mariko; Kurahashi, Hiroki; Noguchi, Satoru; Sese, Jun; Okinaga, Takeshi; Tsukahara, Toshifumi; Guicheney, Pascale; Ozono, Keiichi; Nishino, Ichizo; Morishita, Shinichi; Toda, Tatsushi.

In: Biochemical and Biophysical Research Communications, Vol. 342, No. 2, 07.04.2006, p. 489-502.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?

AU - Ikeda, Mariko

AU - Kurahashi, Hiroki

AU - Noguchi, Satoru

AU - Sese, Jun

AU - Okinaga, Takeshi

AU - Tsukahara, Toshifumi

AU - Guicheney, Pascale

AU - Ozono, Keiichi

AU - Nishino, Ichizo

AU - Morishita, Shinichi

AU - Toda, Tatsushi

PY - 2006/4/7

Y1 - 2006/4/7

N2 - Fukuyama-type congenital muscular dystrophy (FCMD) and laminin-α2 deficient congenital muscular dystrophy (MDC1A) are congenital muscular dystrophies (CMDs) and they both are categorized into the same clinical entity of muscular dystrophy as Duchenne muscular dystrophy (DMD). All three disorders share a common etiologic defect in the dystrophin-glycoprotein complex, which connects muscle structural proteins with the extracellular basement membrane. To investigate the pathophysiology of these CMDs, we generated microarray gene expression profiles of skeletal muscle from patients in various clinical stages. Despite diverse pathological changes, the correlation coefficient of overall gene expression among these samples was considerably high. We performed a multi-dimensional statistical analysis, the Distillation, to extract determinant genes that distinguish CMD muscle from normal controls. Up-regulated genes were primarily extracellular matrix (ECM) components, whereas down-regulated genes included structural components of mature muscle. These observations reflect active interstitial fibrosis with less active regeneration of muscle cell components in the CMDs, characteristics that are clearly distinct from those of DMD. Although the severity of fibrosis varied among the specimens tested, ECM gene expression was consistently high without substantial changes through the clinical course. Further, in situ hybridization showed more prominent ECM gene expression on muscle cells than on interstitial tissue cells, suggesting that ECM components are induced by regeneration process rather than by 'dystrophy.' These data imply that the etiology of FCMD and MDC1A differs from that of the chronic phase of classical muscular dystrophy, and the major pathophysiologic change in CMDs might instead result from primary active fibrosis.

AB - Fukuyama-type congenital muscular dystrophy (FCMD) and laminin-α2 deficient congenital muscular dystrophy (MDC1A) are congenital muscular dystrophies (CMDs) and they both are categorized into the same clinical entity of muscular dystrophy as Duchenne muscular dystrophy (DMD). All three disorders share a common etiologic defect in the dystrophin-glycoprotein complex, which connects muscle structural proteins with the extracellular basement membrane. To investigate the pathophysiology of these CMDs, we generated microarray gene expression profiles of skeletal muscle from patients in various clinical stages. Despite diverse pathological changes, the correlation coefficient of overall gene expression among these samples was considerably high. We performed a multi-dimensional statistical analysis, the Distillation, to extract determinant genes that distinguish CMD muscle from normal controls. Up-regulated genes were primarily extracellular matrix (ECM) components, whereas down-regulated genes included structural components of mature muscle. These observations reflect active interstitial fibrosis with less active regeneration of muscle cell components in the CMDs, characteristics that are clearly distinct from those of DMD. Although the severity of fibrosis varied among the specimens tested, ECM gene expression was consistently high without substantial changes through the clinical course. Further, in situ hybridization showed more prominent ECM gene expression on muscle cells than on interstitial tissue cells, suggesting that ECM components are induced by regeneration process rather than by 'dystrophy.' These data imply that the etiology of FCMD and MDC1A differs from that of the chronic phase of classical muscular dystrophy, and the major pathophysiologic change in CMDs might instead result from primary active fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=33344460712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344460712&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.12.224

DO - 10.1016/j.bbrc.2005.12.224

M3 - Article

VL - 342

SP - 489

EP - 502

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -